UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
Amendment No. 1
(Mark One)
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended: May 31, 2016
or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________________________ to __________________________
Commission file number 333-168337
GROGENESIS, INC.
(Exact name of registrant as specified in its charter)
Nevada | 42-1771870 |
State or other jurisdiction | (I.R.S. Employer |
of incorporation or organization | Identification No.) |
101 S. Reid Street, Suite 307, Sioux Falls, SD 57103
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (605) 836-3100
N/A
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Name of each exchange on which registered |
None | N/A |
Securities registered pursuant to section 12(g) of the Act:
Shares of common stock with a par value of $0.001
(Title of class)
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [ ] No [X]
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [X]
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [_]
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ] | Accelerated filer [ ] |
Non-accelerated file [ ] (Do not check if a smaller reporting company) | Smaller reporting company [X] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes [ ] No [X]
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $6,683,181
APPLICABLE ONLY TO CORPORATE REGISTRANTS
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: 91,293,178 shares of common stock as of August 29, 2016.
DOCUMENTS INCORPORATED BY REFERENCE
None.
2
EXPLANATORY NOTE
GroGenesis, Inc. (“we”, “our” and “us”) is filing this Amendment No. 1 on Form 10-K/A to amend its Annual Report on Form 10-K for the fiscal year ended May 31, 2016, filed on August 29, 2016. The purpose of this Form 10-K/A, Amendment No. 1, is to amend the signature pages on which we are correcting certain typographical errors.
Other than furnishing the information identified above, this report does not modify or update the disclosure in the Form 10-K in any way.
3
TABLE OF CONTENTS
| Page |
|
|
SIGNATURES | 5 |
4
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
GROGENESIS, INC.
By: /s/ Richard Kamolvathin |
|
Richard Kamolvathin |
|
Chief Executive Officer and Chief Financial Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) |
|
Date: September 2, 2016 |
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: /s/ Grant Walsh |
|
Grant Walsh |
|
Chairman of the Board of Directors |
|
Date: September 2, 2016 |
|
|
|
By: /s/ Richard Kamolvathin |
|
Richard Kamolvathin |
|
Director |
|
Date: September 2, 2016 |
|
|
|
By: /s/ William Gerald Platt |
|
William Gerald Platt |
|
Director |
|
Date: September 2, 2016 |
|
|
|
By: /s/ Brian Yale |
|
Brian Yale |
|
Director |
|
Date: September 2, 2016 |
|
|
|
By: /s/ David E. Colburn |
|
David E. Colburn |
|
Director |
|
Date: September 2, 2016 |
|
5